CD30 expression is not normally detected in healthy tissue outside of the immune system, however high levels of CD30 expression are found in Hodgkin lymphoma (HL) and ALCL, making it an attractive target for antibody-based immunotherapy. The gene discussed is TNFRSF8; the disease is anaplastic large cell lymphoma.